Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
143.33B
Market cap143.33B
Price-Earnings ratio
14.39
Price-Earnings ratio14.39
Dividend yield
3.84%
Dividend yield3.84%
Average volume
13.59M
Average volume13.59M
High today
$69.20
High today$69.20
Low today
$64.14
Low today$64.14
Open price
$66.06
Open price$66.06
Volume
32.97M
Volume32.97M
52 Week high
$69.20
52 Week high$69.20
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $65.46, giving the company a market capitalization of 143.33B. It carries a P/E multiple of 14.39 and pays a dividend yield of 3.84%.

During the trading session on 2026-08-03, Bristol-Myers Squibb(BMY) shares reached a daily high of $69.20 and a low of $64.14. At a current price of $65.46, the stock is +2.1% higher than the low and still -5.4% under the high.

Trading activity shows a volume of 32.97M, compared to an average daily volume of 13.59M.

The stock's 52-week range extends from a low of $42.52 to a high of $69.20.

The stock's 52-week range extends from a low of $42.52 to a high of $69.20.

BMY News

24/7 Wall St. 10h
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way” - 24/7 Wall St.

...

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way” - 24/7 Wall St.
TipRanks 11h
Bristol-Myers Squibb Clears Key Heart-Safety Milestone for BMS-986278

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...

Seeking Alpha 11h
Potential AstraZeneca purchase of Bristol-Myers unlikely for now - analyst

A potential AstraZeneca (AZN) acquisition of Bristol-Myers Squibb (BMY) is unlikely to happen now after a report that the pharma giants have held deal talks, ac...

Potential AstraZeneca purchase of Bristol-Myers unlikely for now - analyst

Analyst ratings

65%

of 31 ratings
Buy
32.3%
Hold
64.5%
Sell
3.2%

More BMY News

MarketWatch 17h
AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

“Odd” is the word analysts are using to describe a potential Bristol-Myers Squibb tie-up with AstraZeneca. AstraZeneca shares were slumping while Bristol Myers...

AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
TipRanks 4d
Bristol-Myers Squibb: Strong Q2 Beat, Intact Pipeline Support Buy Rating as Jason Gerberry Raises Price Target from $66 to $71

Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Bristol-Myers Squibb yesterday and set a price target of $71.00. Claim 55% Off TipR...

Nasdaq 4d
Bristol-Myers Squibb Q2 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Bristol-Myers Squibb Q2 2026 Earnings Call Transcript
The Motley Fool 4d
Why Bristol Myers Squibb Stock Topped the Market on Thursday

Not for the first time this year, Bristol Myers Squibb (BMY +2.79%) posted an impressive quarterly earnings report Thursday morning. Investors clearly found muc...

Why Bristol Myers Squibb Stock Topped the Market on Thursday
Nasdaq 4d
Bristol Myers Squibb Shares Cross 4% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel , in trading on Tuesday, shares of Bristol Myers Squibb Co. (Symbol: BMY) were yielding above the...

Bristol Myers Squibb Shares Cross 4% Yield Mark
Benzinga 4d
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

• Bristol-Myers Squibb stock is showing upward movement. Why are BMY shares climbing? The U.S. large pharma company reported adjusted earnings of $2.04, beatin...

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength
TipRanks 5d
Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating

William Blair analyst Matt Phipps has maintained their neutral stance on BMY stock, giving a Hold rating on July 27. Unlock powerful investing tools with TipRa...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.